Insiders · HLSQ

Michael E. Dambach

Director at BiomX Inc. (HLSQ) since May 2023

Michael E. Dambach has filed 2 insider reports with the SEC since May 2023, as director at BiomX Inc. (HLSQ). The latest filing, on August 23, 2023, reports grant or award at BiomX Inc. (HLSQ).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Michael E. Dambach is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
BiomX Inc. logo
HLSQ
BiomX Inc.
Directorsince May 2023$0.0717Aug 23, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Michael E. Dambach with

Other insiders at the same companies

Questions about Michael E. Dambach

What is Michael E. Dambach's role at BiomX Inc.?
Michael E. Dambach reports to the SEC as director at BiomX Inc. (HLSQ), according to the latest filing on August 23, 2023.
Has Michael E. Dambach bought or sold stock recently?
No open-market purchases or sales by Michael E. Dambach are on file. The filings report grant or award.
How do I get alerts when Michael E. Dambach files?
Follow Michael E. Dambach on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Michael E. Dambach (SEC CIK 0001977134). Totals count each trade once, skipping amendments whose original is on file, from May 19, 2023 on. View on SEC EDGAR · Get this as JSON